Seeing Is Believing
Currently out of the existing stock ratings of Kerry Holford, 9 are a HOLD (75%), 3 are a BUY (25%).
Analyst Kerry Holford works at BERENBERG with a stock forecast success ratio of 50% fulfilled within 105.5 days on average.
Kerry Holford’s has documented 34 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 05-Dec-2023.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 10/11/2021. The price target of $270 was fulfilled within 66 days with a profit of $42.84 (18.86%) receiving and performance score of 2.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
44
$3.15 (7.71%)
18.72
2 months 28 days ago
0/14 (0%)
$5.1 (13.11%)
Buy
48
$7.15 (17.50%)
39
3 months 17 days ago
1/3 (33.33%)
$9.46 (24.55%)
265
Hold
19.52
$-21.33 (-52.22%)
18.9
8 months 6 days ago
0/3 (0%)
$-14.87 (-43.24%)
Hold
19.58
$-22.45 (-53.41%)
19.96
11 months 30 days ago
0/2 (0%)
$-16.05 (-45.05%)
Buy
21.66
1 years 1 months 3 days ago
0/13 (0%)
$-19.7 (-47.63%)
Which stock is Kerry Holford is most bullish on?
What Year was the first public recommendation made by Kerry Holford?